You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CD34

Showing 1 - 25 of 5,284
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AML, ALL, Lymphoid Malignancies Trial in Birmingham (Infusion of CD34 selected hematopoietic stem cells)

Not yet recruiting
  • AML
  • +5 more
  • Infusion of CD34 selected hematopoietic stem cells
  • Birmingham, Alabama
    University of Alabama at Birmingham
Sep 14, 2023

Sickle Cell Disease Trial in Paris (DREPAGLOBE drug product)

Active, not recruiting
  • Sickle Cell Disease
  • DREPAGLOBE drug product
  • Paris, France
    Department of Biotherapy, Necker-Enfants Malades Hospital
Sep 26, 2022

MDS, Graft Vs Host Disease, Graft-versus-host-disease Trial in Miami (Busulfan, Melphalan, Fludarabine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Miami, Florida
    Miami Cancer Institute
Jan 10, 2023

B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

Not yet recruiting
  • B-cell Non Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • Cyclophosphamide injection
  • +2 more
  • Charleston, South Carolina
    Hollings Cancer Center at Medical University of South Carolina
Jan 18, 2023

Retinitis Pigmentosa Trial in Sacramento (Intravitreal autologous CD34+ cells)

Recruiting
  • Retinitis Pigmentosa
  • Intravitreal autologous CD34+ cells
  • Sacramento, California
    University of California Davis
Sep 1, 2022

Mitochondrial Diseases, Pearson Syndrome Trial in Ramat Gan (MNV-201)

Recruiting
  • Mitochondrial Diseases
  • Pearson Syndrome
  • MNV-201
  • Ramat Gan, Israel
    Sheba Medical Center
Aug 24, 2023

Mucopolysaccharidosis II Trial (Autologous CD34+ HSCs transduced ex vivo with CD11B LV encoding human IDS tagged with ApoEII)

Not yet recruiting
  • Mucopolysaccharidosis II
  • Autologous CD34+ HSCs transduced ex vivo with CD11B LV encoding human IDS tagged with ApoEII
  • (no location specified)
Dec 16, 2022

Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in Miami (Total Body Irradiation (TBI), Thiotepa, Cyclophosphamide)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • Leukemia, Lymphocytic, Acute
  • Total Body Irradiation (TBI)
  • +5 more
  • Miami, Florida
    Baptist Health South Florida/Miami Cancer Institute
Nov 28, 2022

Metastatic Non-Small Cell Lung Carcinoma Trial in Seoul (Pembrolizumab Injection)

Recruiting
  • Metastatic Non-Small Cell Lung Carcinoma
  • Pembrolizumab Injection
  • Seoul, Korea, Republic of
    Samsung Medical Center
Nov 6, 2022

Hematologic Disorders Trial in Aurora (Miltenyi CliniMACS® CD34 Reagent System)

Recruiting
  • Hematologic Disorders
  • Miltenyi CliniMACS® CD34 Reagent System
  • Aurora, Colorado
    University of Colorado
Feb 22, 2022

P47-Phox, Deficiency of Trial in London (Lentiviral vector transduced CD34+ cells)

Not yet recruiting
  • P47-Phox, Deficiency of
  • Lentiviral vector transduced CD34+ cells
  • London, United Kingdom
    Great Ormond Street Hospital
Aug 2, 2022

Lymphoma, Peripheral Blood Stem Cell Transplantation Trial (Eltrombopag olamine)

Not yet recruiting
  • Lymphoma
  • Peripheral Blood Stem Cell Transplantation
  • Eltrombopag olamine
  • (no location specified)
Jul 25, 2023

Severe Aplastic Anemia, MDS (Myelodysplastic Syndrome) Trial in Baltimore, Bethesda, Minneapolis (Miltenyi CD34 Reagent System,

Recruiting
  • Severe Aplastic Anemia
  • MDS (Myelodysplastic Syndrome)
  • Miltenyi CD34 Reagent System
  • Donor derived G-CSF mobilized PBC
  • Baltimore, Maryland
  • +2 more
Jan 25, 2023

Sickle Cell Disease Trial in Birmingham, Palo Alto, Saint Louis (GPH101 Drug Product)

Active, not recruiting
  • Sickle Cell Disease
  • GPH101 Drug Product
  • Birmingham, Alabama
  • +2 more
Jan 5, 2023

CD34 + Stem Cells and Biological Markers of Angiogenesis in

Recruiting
  • Vasculopathy
  • Heart Transplant Failure
  • coronary CT angiography
  • Ljubljana, Slovenia
    Advanced Heart Failure and Transplantation Center, University Me
Aug 2, 2022

Sickle Cell Disease Trial in Saint Louis (Motixafortide, Natalizumab, Leukapheresis)

Not yet recruiting
  • Sickle Cell Disease
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 8, 2022

Apheresis of Patients With Immunodeficiency

Recruiting
  • LAD-1
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Adenosine Deaminase Severe Combined Immune Deficiency Trial (A cryopreserved formulation of autologous mPB CD34+ hematopoietic

    Not yet recruiting
    • Adenosine Deaminase Severe Combined Immune Deficiency
    • A cryopreserved formulation of autologous mPB CD34+ hematopoietic stem and progenitor cells transduced ex vivo with the EFS-ADA lentiviral vector encoding the human ADA enzyme
    • (no location specified)
    Jun 20, 2022

    Hematologic Diseases, Hematologic Malignancy, Acute Lymphoblastic Leukemia Trial in Miami (device, procedure, drug)

    Withdrawn
    • Hematologic Diseases
    • +5 more
    • CliniMACS
    • +7 more
    • Miami, Florida
      Miami Cancer Institute at Baptist Health, Inc.
    Sep 26, 2022

    Non-exudative Age-related Macular Degeneration, Diabetic Retinopathy, Retina Vein Occlusion Trial in Sacramento (CD34+ bone

    Enrolling by invitation
    • Non-exudative Age-related Macular Degeneration
    • +4 more
    • CD34+ bone marrow stem cells intravitreal
    • Sacramento, California
      University of California Davis
    Aug 8, 2022

    ß-thalassemia Trial (BD211)

    Not yet recruiting
    • β-thalassemia
    • BD211
    • (no location specified)
    Mar 15, 2023

    B-Cell Acute Lymphoblastic Leukemia, Adult, B-cell Lymphoma Refractory, B-cell Lymphoma Recurrent Trial in Maywood (Fludarabine,

    Active, not recruiting
    • B-Cell Acute Lymphoblastic Leukemia, Adult
    • +2 more
    • Maywood, Illinois
      Loyola University
    Aug 11, 2022

    Chronic Myeloid Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Atlanta (G-CSF mobilized CD34+ selected

    No longer available
    • Chronic Myeloid Leukemia
    • +2 more
    • G-CSF mobilized CD34+ selected cells for transplantation
    • Atlanta, Georgia
      Emory University/Winship Cancer Institute
    Feb 28, 2022

    Heart Failure, Mechanical Circulatory Support Trial in Ljubljana (CD34+ stem cell therapy)

    Recruiting
    • Heart Failure
    • Mechanical Circulatory Support
    • CD34+ stem cell therapy
    • Ljubljana, Slovenia
      University Medical Center Ljubljana
    Nov 22, 2023

    Acute Myeloid Leukemia Trial in Miami (CPX-351, Midostaurin, Busulfan)

    Recruiting
    • Acute Myeloid Leukemia
    • Miami, Florida
      Miami Cancer Institute at Baptist Health of South Florida
    Jul 27, 2022